JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morimatsu, H.
Right arrow Articles by Morita, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morimatsu, H.
Right arrow Articles by Morita, K.
Related Collections
Right arrow Critical Care
Right arrow Complications
Right arrow Pharmacology

Anesth Analg 2004;99:1205-1207
© 2004 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000130615.28893.52


CRITICAL CARE AND TRAUMA

Rapid Development of Severe Interstitial Pneumonia Caused by Epoprostenol in a Patient with Primary Pulmonary Hypertension

Hiroshi Morimatsu, MD*, Keiji Goto, MD*, Takashi Matsusaki, MD*, Hiroshi Katayama, MD PhD*, Hiromi Matsubara, MD PhD{dagger}, Tohru Ohe, MD PhD{dagger}, and Kiyoshi Morita, MD PhD

Departments of *Anesthesiology and Intensive Care and {dagger}Cardiology, Okayama University Medical School, Okayama, Japan

Address correspondence and reprint requests to Hiroshi Morimatsu, MD, Department of Anesthesiology and Intensive Care, Okayama University Medical School, 2-5-1, Shikata-cho, Okayama 700-8558, Japan. Address e-mail to morimatu{at}pop21.odn.ne.jp

A young woman with primary pulmonary hypertension developed severe interstitial pneumonia (IP) 5 days after induction of epoprostenol infusion. Although the pathogen involved was not identified, her IP was initially responsive to steroids, and discontinuation of steroid therapy caused the redevelopment of IP. After intensive treatment, including steroid therapy and inhaled nitric oxide, epoprostenol was successfully switched to prostaglandin E1 infusion and she recovered. Epoprostenol infusion can cause a rapid severe IP, even soon after the induction of therapy. Clinicians should keep this syndrome in mind, especially when treating a severe case of IP.

IMPLICATIONS: Epoprostenol infusion can cause a rapid, severe interstitial pneumonia (IP), even soon after the induction of therapy. Clinicians should keep this syndrome in mind, especially when treating a severe case of IP.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2004 by the International Anesthesia Research Society.